CHEWY Earnings Results: $CHWY Reports Quarterly Earnings

Chewy reported Q1 2025 earnings of $0.35 per share, surpassing estimates of $0.20, but missed revenue expectations, reporting $3.116 billion against an estimated $3.143 billion. Over the last six months, Chewy insiders have predominantly sold shares, while hedge fund activity has been mixed, with some firms significantly increasing their positions (Holocene Advisors, Invesco LTD, Morgan Stanley) and others reducing them (BC Partners, Baillie Gifford, Balyasny Asset Management). Wall Street analysts are generally positive on the stock, with 4 "Buy" ratings and a median price target of $42.00.

Analysis

Chewy ($CHWY) presented a mixed financial picture in its recent quarterly earnings report, posting earnings per share of $0.35, which surpassed analyst estimates of $0.20 by a significant $0.15. However, the company's revenue of $3.116 billion slightly missed expectations of $3.143 billion by $26.67 million. This earnings beat is contrasted by considerable insider selling activity over the past six months, with 51 sales transactions and no purchases recorded. Notably, HOLDINGS GP LLC ARGOS sold 26,827,242 shares for an estimated $871.4 million, CEO Sumit Singh divested 1,845,024 shares for approximately $68.3 million, CFO David Reeder sold 542,361 shares for around $20.4 million, and CTO Satish Mehta sold 445,240 shares for roughly $16.6 million. Hedge fund activity shows divergent strategies: 282 institutional investors added CHWY shares while 237 reduced their positions. Significant moves included Holocene Advisors L.P. adding 10.68 million shares (+14924.1%) and Invesco Ltd. adding 3.12 million shares (+142.5%) in Q1 2025, whereas BC Partners Advisors L.P. reduced its stake by 21.08 million shares (-8.5%) in Q4 2024, and Baillie Gifford & Co removed 10.58 million shares (-63.9%) in Q1 2025. Despite the revenue miss and insider sales, Wall Street analysts remain broadly positive, with four firms issuing buy-equivalent ratings recently, including Cowen & Co. and Guggenheim. The median analyst price target for CHWY is $42.00, with a range from $27.00 (Deutsche Bank) to $47.00 (Mizuho Securities), indicating varied expectations. The per-ticker sentiment for CHWY is moderately negative at -0.4, likely reflecting the revenue shortfall and the high volume of insider sales.

Key Decisions for Investors

• Investors should weigh Chewy's robust earnings per share outperformance against the marginal revenue miss and the significant volume of insider sales, particularly from top executives.
• The positive consensus among Wall Street analysts, evidenced by four recent 'Buy' ratings and a median price target of $42.00, suggests underlying confidence in the company's strategy, but the wide dispersion in price targets ($27.00 to $47.00) warrants careful consideration of individual risk tolerance.
• Monitor future revenue growth trends, shifts in institutional ownership patterns, and any further insider transactions closely, as these will be key indicators for assessing the sustainability of Chewy's growth trajectory and resolving the current mixed signals.